Medarex Stubs Its Toe (MEDX, BMY, DNDN)
Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the hopes for its Ipilimumab Pivotal Trials in patients with Advanced ...Read Full Story »

